SCHW
52
3
BRK.B
42
-3
ETR
68
2
AIV
71
9
FTI
82
4
TXN
50
-3
SHW
71
-2
BWA
45
-4
MAT
51
-3
HAS
55
-2
MCD
67
2
HOG
50
6
WBA
24
-3
VRTX
53
-2
FOXA
48
7
XRAY
31
-3
PPG
61
-5
CF
57
-3
MDLZ
65
-2
ED
53
4
SCHW
52
3
BRK.B
42
-3
ETR
68
2
AIV
71
9
FTI
82
4
TXN
50
-3
SHW
71
-2
BWA
45
-4
MAT
51
-3
HAS
55
-2
MCD
67
2
HOG
50
6
WBA
24
-3
VRTX
53
-2
FOXA
48
7
XRAY
31
-3
PPG
61
-5
CF
57
-3
MDLZ
65
-2
ED
53
4
Financhill
Back

Vir Biotechnology Quote, Financials, Valuation and Earnings

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
19

VIR
Vir Biotechnology

Last Price:
7.78
Seasonality Move:
6.96%

7 Day Trial

ALL ACCESS PASS

$ 7

10 minutes on Tuesday - $1,270 by Friday?

Click here to discover how this "odd" trade could double your money each week.

Vir Biotechnology Price Quote

$7.78
+0.02 (+-2.02%)
(Updated: September 21, 2024 at 6:49 AM ET)

Vir Biotechnology Key Stats

Sell
19
Vir Biotechnology (VIR) is a Sell
Day range:
$7.76 - $7.91
52-week range:
$7.41 - $13.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.20
P/B ratio:
0.74%
Volume:
912.8K
Avg. volume:
685.5K
1-year change:
-17.13%
Market cap:
$1.1B
Revenue:
$39.5M
EPS:
$-3.58

How Much Does Vir Biotechnology Make?

Is Vir Biotechnology Growing As A Company?

Data Unavailable

Vir Biotechnology Stock Price Performance

  • Did Vir Biotechnology Stock Go Up Last Month?
    Vir Biotechnology share price went down by -11.86% last month
  • Did VIR's Share Price Rise Over The Last Year?
    VIR share price fell by -17.13% over the past 1 year

What Is Vir Biotechnology 52-Week High & Low?

Vir Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vir Biotechnology?

  • How Much Debt Does Vir Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vir Biotechnology Have?
    Cash and short term investments quarterly total is $1.2B
  • What Is Vir Biotechnology’s Book Value Per Share?
    Book value per share is 10.50

Is Vir Biotechnology Cash Flow Positive?

  • What Is VIR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$451M
  • What Is Vir Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.1M
  • What Is Vir Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $76.3M

Vir Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    VIR return on invested capital is -29.98%
  • What Is Vir Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is -24.97%
  • What Is VIR Return On Equity?
    ROE is a measure of profitability and is -29.98%

Vir Biotechnology Earnings Date & Stock Price

Vir Biotechnology Competitors

  • Who Are Vir Biotechnology's Competitors?
    Below is a list of companies who compete with Vir Biotechnology or are related in some way:
    • Axsome Therapeutics Inc (AXSM)
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Pfizer Inc (PFE)

Vir Biotechnology Dividend Yield

Vir Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -14.05%
Revenue: 0% -58.98%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 31.25
Upside from Last Price: 302.45%

Major Shareholders

  • How many VIR shares are owned by institutional investors?
    134.5M VIR shares are owned by institutional investors
  • How many VIR shares are owned by insiders?
    4.8M VIR shares are owned by insiders